Anti-RANKL therapy—implications for the bone-vascular-axis in CKD? Denosumab in post-menopausal women with low bone mineral density**Comment on McClung MR, Lewiecki EM, Cohen SB et al. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 2006; 354: 821–831

Subjects

Subjects :

Oncology
Bone mineral
Transplantation
medicine.medical_specialty
biology
business.industry
Osteoporosis
Post menopausal
medicine.disease
Denosumab
Osteoprotegerin
Nephrology
RANKL
Internal medicine
medicine
biology.protein
business
Vascular calcification
medicine.drug

Details

ISSN :

14602385 and 09310509

Volume :

21

Database :

OpenAIRE

Journal :

Nephrology Dialysis Transplantation

Accession number :

edsair.doi...........a2ff3650aa1af3789c7ab4a364864573

Full Text :

https://doi.org/10.1093/ndt/gfl245